ArticleJournal for immunotherapy of cancer2026

Tumor immune microenvironment facilitates resistance to KRAS G12C inhibitor sotorasib by altered PD-L1 expression.

Shougeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.